Executive Director Medical Affairs Strategy - Oncology Portfolio
Executive Director Medical Affairs Strategy - Oncology Portfolio
Posted on :
20-01-2025
Employer Active
1 Vacancy
Job Alert
You will be updated with latest job alerts via emailValid email field required
Send jobs
Share
Send me jobs like this
Job Alert
You will be updated with latest job alerts via emailValid email field required
Send jobs
Monthly Salary
Not Disclosed
Salary Not Disclosed
Vacancy
1 Vacancy
Posted on :
20-01-2025
Job Description
Job Title: Executive Director Medical Affairs Strategy Oncology Portfolio
Job Location: United States
Job Location Type: Remote
Job Contract Type: Fulltime
Job Seniority Level: Executive
Arvinas is a clinicalstage biotechnology company dedicated to improving the lives of patients suffering from debilitating and lifethreatening diseases through the discovery development and commercialization of therapies that degrade diseasecausing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras or PROTAC® targeted protein degraders that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove diseasecausing proteins.
In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets the company has three investigational clinicalstage programs currently enrolling: vepdegestrant for the treatment of patients with locally advanced or metastatic ER/HER2 breast cancer; ARV102 for the treatment of patients with neurodegenerative disorders associated with LRRK2 and ARV393 for the treatment of patients with relapsed/refractory nonHodgkin Lymphoma and potentially other lymphomas.
In April 2024 Arvinas entered into a transaction with Novartis including a global license agreement for the development and commercialization of the clinical stage PROTAC® androgen receptor protein degrader ARV766 for the treatment of prostate cancer. The transaction closed in May 2024.
#TeamArvinas is made up of approximately 450 passionate and curious employees whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation think creatively and give back. They are driven by the company’s values and mission – to improve the lives of patients with serious diseases by pioneering therapies created with our revolutionary PROTAC® protein degradation platform. We’re really excited about the work we’re doing inside and outside of Arvinas and think you will be too. But don’t just take our word for it – learn more about life at Arvinas and what employees have to say.
For more information please visit
Position Summary
Arvinas has an outstanding opportunity for an experienced medical affairs leader to play a pivotal role in shaping medical affairs strategy and tactical plans for the Arvinas oncology portfolio. The Executive Director is a key member of the Medical Affairs Leadership Team and will manage the medical strategy team consisting of medical directors and a patient advocacy director working across the oncology portfolio. The Executive Director will provide strategic input into the oncology global asset teams either directly or through oversight of the medical strategy team members assigned to the asset teams. This role will also ensure medical affairs launch readiness as we prepare for the launch of Arvinas’ first product. The Executive Director will collaborate with crossfunctional leaders across the organization including those in clinical development commercial regulatory corporate communications and investor relations.
The Executive Director will report to the Vice President of Medical Affairs and will be located remotely from a location within the U.S.
Principal Responsibilities
Key responsibilities of this role include but are not limited to:
Arvinas is an Equal Opportunity Employer
In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets the company has three investigational clinicalstage programs currently enrolling: vepdegestrant for the treatment of patients with locally advanced or metastatic ER/HER2 breast cancer; ARV102 for the treatment of patients with neurodegenerative disorders associated with LRRK2 and ARV393 for the treatment of patients with relapsed/refractory nonHodgkin Lymphoma and potentially other lymphomas.
In April 2024 Arvinas entered into a transaction with Novartis including a global license agreement for the development and commercialization of the clinical stage PROTAC® androgen receptor protein degrader ARV766 for the treatment of prostate cancer. The transaction closed in May 2024.
#TeamArvinas is made up of approximately 450 passionate and curious employees whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation think creatively and give back. They are driven by the company’s values and mission – to improve the lives of patients with serious diseases by pioneering therapies created with our revolutionary PROTAC® protein degradation platform. We’re really excited about the work we’re doing inside and outside of Arvinas and think you will be too. But don’t just take our word for it – learn more about life at Arvinas and what employees have to say.
For more information please visit
Position Summary
Arvinas has an outstanding opportunity for an experienced medical affairs leader to play a pivotal role in shaping medical affairs strategy and tactical plans for the Arvinas oncology portfolio. The Executive Director is a key member of the Medical Affairs Leadership Team and will manage the medical strategy team consisting of medical directors and a patient advocacy director working across the oncology portfolio. The Executive Director will provide strategic input into the oncology global asset teams either directly or through oversight of the medical strategy team members assigned to the asset teams. This role will also ensure medical affairs launch readiness as we prepare for the launch of Arvinas’ first product. The Executive Director will collaborate with crossfunctional leaders across the organization including those in clinical development commercial regulatory corporate communications and investor relations.
The Executive Director will report to the Vice President of Medical Affairs and will be located remotely from a location within the U.S.
Principal Responsibilities
Key responsibilities of this role include but are not limited to:
- Lead mentor and develop the medical strategy team consisting of medical directors and a patient advocacy director working across the oncology portfolio
- Oversee the development and execution of medical affairs strategy and plans to support the Arvinas oncology portfolio across all stages – from early development to launch and throughout the product lifecycle
- Ensure medical affairs launch readiness
- Serve as Core member and/or oversee medical strategy team members on the global asset teams (development teams)
- Oversee the implementation and functioning of the assetspecific medical subteams (MSTs) to develop and execute on medical strategies and tactics
- Provide crossportfolio medical affairs representation on the publication planning committees. Participate in data analysis efforts and lead in manuscript abstract and poster development
- Oversee crossportfolio medical affairs research program (including collaborative studies investigator sponsored research and HEOR/RWD studies in partnership with HEOR Lead)
- Collaborate closely with medical affairs functions including those in scientific communications publications field medical health outcomes and economic research and medical affairs operations
- Collaborate closely crossfunctional partners including those in clinical development clinical operations commercial translational corporate communications and investor relations
- Model leadership behaviors consistent with Arvinas values
- 15 years of relevant oncology experience with at least 10 years of Medical Affairs experience in pharmaceutical/biopharmaceutical industry
- Matrix team leadership required candidates with direct managerial experience highly preferred
- Demonstrated ability to think strategically and translate medical affairs strategy into an actionable plan
- Strong interpersonal skills and excellent verbal communication and presentation skills.
- Proven ability to facilitate open discussion and debate among key stakeholders and build internal and external relationships.
- Wellorganized with the ability to be flexible prioritize multiple demands and effectively lead in a matrix organization.
- Growth mindset with demonstrated ability to perform playercoach activities
- Proficiency in clinical trial data review and interpretation
- Ideal candidate has both US and Global medical affairs experience and breast cancer experience.
- Ability to travel 20% of time
- Remote (Home office based): The duties of this role are generally conducted in a home office environment. Employees must be able with or without an accommodation to use a computer; engage in communications via phone video and electronic messaging; engage in problem solving and nonlinear thought analysis and dialogue; collaborate with others; maintain general availability during standard business hours.
- Must be legally authorized to work in the US without the need for employer sponsorship now or at any time in the future.
- MD PhD or PharmD required
Arvinas is an Equal Opportunity Employer
/jobs/view/eb47746ef581eebf9f24f0278b0a5834
Employment Type
Full Time
Key Skills
Report This Job
Disclaimer: Drjobpro.com is only a platform that connects job seekers and employers. Applicants are advised to conduct their own independent research into the credentials of the prospective employer.We always make certain that our clients do not endorse any request for money payments, thus we advise against sharing any personal or bank-related information with any third party. If you suspect fraud or malpractice, please contact us via contact us page.
